Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis

Journal of Bone and Mineral Research

Volumn 20, Issue 5, 2005, Pages 764-772

  Raggi, Paolo ^a   James, George ^a   Burke, Steven K ^b   Bommer, Jürgen ^c   Chasan Taber, Scott ^d   Holzer, Herwig ^e   Braun, Johan ^f   Chertow, Glenn M ^g  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Genzyme Drug Discovery and Development   (United States)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d Pioneer BioDiligence   (United States)

^e UNIVERSITY HOSPITAL GRAZ   (Austria)

^f KfH Dialyzezeritrum Nurnberg   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone; Calcium; Clinical trial; Hemodialysis; Hounsfield units; Sevelamer

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; CALCIUM PHOSPHATE; CALCIUM SALT; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER;

ADULT; AGED; ARTICLE; BONE TURNOVER; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; ELECTRON BEAM TOMOGRAPHY; FEMALE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; OSTEODYSTROPHY; PHOSPHATE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SOFT TISSUE CALCIFICATION; THORACIC SPINE; TRABECULAR BONE; VERTEBRA;

AGED; ALKALINE PHOSPHATASE; AORTA; BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; ELECTRONS; EPOXY COMPOUNDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATE-BINDING PROTEINS; PHOSPHATES; PHOSPHORUS; POLYAMINES; POLYETHYLENES; POLYMERS; RENAL DIALYSIS; SERUM; SPINE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 17644395611     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041221     Document Type: Article

References (45)

1. Goldman R, Bassett SH 1954 Phosphorus excretion in renal failure. J Clin Invest 33:1623-1630.
2. Delmez JA, Slatopolsky E 1992 Hyperphosphatemia: Its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis 19:303-317.
3. Martinez I, Saracho R, Montenegro J, Llach F 1997 The importance of dietary calcium and phosphorous in the secondary hyperparathyroidism of patients with early renal failure. Am J Kidney Dis 29:496-502.
4. Hsu CY, Chertow GM 2002 Elevations of serum phosphorus and potassium in mild to moderate chronic renal insufficiency. Nephrol Dial Transplant 17:1419-1425.
5. Llach F, Velasquez Forero F 2001 Secondary hyperparathyroidism in chronic renal failure: Pathogenic and clinical aspects. Am J Kidney Dis 38:S20-S33.
6. Galceran T, Martin KJ, Morrissey JJ, Slatopolsky E 1987 Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone. Kidney Int 32:801-807.
7. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH 1994 Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855-861.
8. Monier-Faugere MC, Malluche HH 1996 Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients. Nephrol Dial Transplant 11(Suppl 3):111-120.
9. Malluche HH, Sawaya BP, Faugere MC 1995 Dialysis: Current status, contemporary limitations and future challenges. Kidney Int Suppl 50:37-39.
10. Parfitt MA 2003 Renal bone disease: A new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens 12:387-403.
11. Couttenye MM, D'Haese PC, Verschoren WJ, Behets GJ, Schrooten I, De Broe ME 1999 Low bone turnover in patients with renal failure. Kidney Int Suppl 73:S70-S76.
12. Jono S, McKee M, Murray CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM 2000 Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:E10-E17.
13. Ahmed S, O'Neill KD, Hood AF, Evan AP, Moe SM 2001 Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37:1267-1276.
14. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke SK, Chertow GM 2002 Cardiac calcification in adult hemodialysis patients: A link between ESRD and cardiovascular disease? J Am Coll Cardiol 39:695-701.
15. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483.
16. Chertow GM, Burke SK, Raggi P 2002 Sevelamer attenuates the progression of coronary artery and aortic calcification in hemodialysis patients. Kidney Int 62:245-252.
17. Plone MA, Petersen JS, Rosenbaum DP, Burke SK 2002 Sevelamer, a phosphate-binding polymer, is a non-absorbed compound. Clin Pharmacokinet 41:517-523.
18. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R 1990 Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827-832.
19. Lenchik L, Shi R, Register TC, Beck SR, Langefeld CD, Carr JJ 2004 Measurement of trabecular bone mineral density in the thoracic spine using cardiac gated quantitative computed tomography. J Compt Assist Tomogr 28:134-139.
20. Budoff MJ, Mao S, Lu B, Takasu J, Child J, Carson S, Fisher H 2002 Ability of calibration phantom to reduce the interscan variability in electron beam computed tomography. J Comput Assist Tomogr 26:886-891.
21. Hesch RD, Brabant G, Rittinghaus EF, Atkinson MJ, Harms H 1988 Pulsatile secretion of parathyroid hormone and its action on a type I and type II PTH receptor: A hypothesis for understanding osteoporosis. Calcif Tissue Int 42:341-344.
22. Schmitt CP, Huber D, Mehls O, Maiwald J, Stein G, Veldhuis JD, Ritz E, Schaefer F 1998 Altered instantaneous and calcium-modulated oscillatory PTH secretion patterns in patients with secondary hyperparathyroidism. J Am Soc Nephrol 9:1832-1844.
23. Schmitt CP, Schaefer F, Huber D, Zahn I, Veldhuis JD, Ritz E, Mehls O 1998 1,25(OH)2-vitamin D3 reduces spontaneous and hypocalcemia-stimulated pulsatile component of parathyroid hormone secretion. J Am Soc Nephrol 9:54-62.
24. Sherrard DJ, Hercz G, Pei Y, Maloney NA, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV 1993 The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442.
25. Chertow GM, Burke SK, Dillon MA, Slatopolsky E 1999 Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients. Nephrol Dial Transplant 14:2907-2914.
26. Parhami F, Morrow AD, Balucan J, Leitinger N, Watson AD, Tintut Y, Berliner JA, Demer LL 1997 Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol 17:680-687.
27. Tintut Y, Parhami F, Tsingotjidou A, Tetradis S, Territo M, Demer LL 2002 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem 19:14221-14226.
28. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949.
29. Oxlund H, Dalstra M, Andreassen TT 2001 Statin given perorally to adult rats increases cancellous bone mass and compressive strength. Calcif Tissue Int 69:299-304.
30. Sirola J, Sirola J, Honkanen R, Kroger H, Jurvelin JS, Maenpaa P, Saarikoski S 2002 Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women. Osteoporos Int 13:537-541.
31. LaCroix AZ, Cauley JA, Pettinger M, Hsia J, Bauer DC, McGowan J, Chen Z, Lewis CE, McNeeley SG, Passaro MD, Jackson RD 2003 Statin use, clinical fracture, and bone density in postmenopausal women: Results from the Women's Health Initiative Observational Study. Ann Intern Med 139:97-104.
32. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T 1999 Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293.
33. Coco M, Rush H 2000 Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis 36:1115-1121.
34. Taal MW, Roe S, Masud T, Green D, Porter C, Cassidy MJ 2003 Total hip bone mass predicts survival in chronic hemodialysis patients. Kidney Int 63:1116-1120.
35. Barengolts EI, Herman M, Kukreja SC, Kouznetsova T, Lin C, Chomka EV 1998 Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women. Calcif Tissue Int 62:209-213.
36. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC 1996 Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401.
37. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM 2001 Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 38:938-942.
38. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul M-C 2004 Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951.
39. Giachelli C 2003 Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 14(Suppl 4):S300-S304.
40. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX 2003 Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003-1011.
41. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bohm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J 2003 Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross-sectional study. Lancet 361:827-833.
42. Ketteler M, Wanner C, Metzger T, Bongartz P, Westenfeld R, Gladziwa U, Schurgers LJ, Vermeer C, Jahnen-Dechent W, Floege J 2003 Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia. Kidney Int Suppl 84:S84-S87.
43. Price PA, June HH, Buckley JR, Williamson MK 2002 SB 242784, a selective inhibitor of the osteoclastic V-H+ATPase, inhibits arterial calcification in the rat. Circ Res 91:547-552.
44. Weishaupt D, Schweitzer ME, DiCuccio MN, Whitley PE 2001 Relationships of cervical, thoracic, and lumbar bone mineral density by quantitative CT. J Comput Assist Tomogr 25:146-150.
45. Sharp DJ, Tanner KE, Bonfield W 1990 Measurement of the density of trabecular bone. J Biomech 23:853-857.